Clinical Trials · NCT01373216
Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Patients With Aortocoronary Bypass
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Charles University, Czech Republic
- Enrollment
- 38
- Start date
- Jun 2011
- Locations
- 1 site, Czechia
- Primary endpoint
- Cardiac function - echocardiographic parameters